Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib
阿布昔替尼治疗特应性皮炎患者的真实世界疗效和安全性:一项为期 16 周的单中心回顾性队列研究,与乌帕昔替尼和巴瑞替尼进行比较
期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-026-01679-0
Gwag, Ho Eun; Park, Minjung; Park, So Yun; Hong, Narang; Heo, Seok Jae; Jung, Hye Jung; Park, Mi Youn; Choi, Yu Sung; Ahn, Jiyoung